Pets at Home Group Plc (PETS)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 239.40 |
|---|---|
| 52-week range | 167.20 – 239.46 |
| Return, 1 month / 3 months | +14.3% / +23.3% |
| Return, 1 year / 3 years | +8.0% / −21.4% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -23.7% |
| Average daily value traded | 219.30M GBX |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pets at Home Group is a British pet care business based in the United Kingdom. It runs pet superstores and smaller stores that offer food, toys, accessories and other supplies for pets, alongside services such as grooming and veterinary care delivered through practices located in its stores. Its customers are pet owners across the country, and the company also operates a loyalty programme and related pet care brands.
Pets at Home Group Plc trades under the code PETS on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pets at Home Group Plc (PETS) trades on the London Exchange in UK. It last closed at GBX 239.40 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 138 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.0% and over the last three months it rose 23.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.3% | ||
| From 52-week high | 0.0% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.3% | ||
| 6-month return | 27.2% | ||
| 12-month return, skipping the last month | -5.6% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 219.30M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +7.9% |
|---|---|
| 1 month | +14.3% |
| 3 months | +23.3% |
| 6 months | +27.2% |
| 1 year | +8.0% |
| 3 years | −21.4% |
| 5 years | −50.3% |
Signals
| 50-day / 200-day average | 214.52 / 198.95 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | GBP 0.0270 |
| 4 Dec 2025 | GBP 0.0470 |
| 5 Jun 2025 | GBP 0.0830 |
| 5 Dec 2024 | GBP 0.0470 |
| 6 Jun 2024 | GBP 0.0830 |
| 7 Dec 2023 | GBP 0.0450 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.